Is Your Medical Spa Ready for the WHO's New GLP-1 Obesity Guidelines?

A New Era in Sun Care: FDA Reviews Bemotrizinol for Sunscreens

Update Understanding Bemotrizinol: A Game Changer for Sunscreens On December 11, 2025, the FDA made an announcement that could significantly change how Americans approach sun protection. The agency has proposed allowing bemotrizinol, a potent UV filter already widely used internationally, to be included in the list of active ingredients permitted in U.S. sunscreens. This groundbreaking development aims to expand consumer options while ensuring effective protection against harmful ultraviolet (UV) rays. Bemotrizinol, commonly referred to as BEMT, offers comprehensive protection against both UVA and UVB rays. Current protections in the U.S. have remained limited, consisting of only 16 active ingredients, compared to the 30+ available in countries like Europe. The FDA's proposal is a much-needed step towards modernizing sunscreen regulations and making better products available to consumers. Key PointsSolutions FDA reviewing the proposal for bemotrizinol inclusion.Complete participation in the public comment process. BEMT offers low absorption and minimal skin irritation.Educate patients on the safety and efficacy of BEMT. Only the third sunscreen ingredient approved for children 6 months and older.Advocate for sunscreen safety for all ages in your practice. Potential for better texture and experience in sunscreen formulation.Engage in discussions about product development with manufacturers. Why Bemotrizinol Matters in the Sunscreen Market The introduction of bemotrizinol has significant implications for the United States, where sunscreen has historically lagged behind global innovations. "With chemical sunscreens, a substantial gap exists in formulation due to a limited number of approved filters,” says cosmetic chemist Victoria Fu. BEMT is among the first proposals for a new chemical sunscreen ingredient in 26 years, following the last addition in 1999. According to Dr. Michelle Henry, a dermatologist, BEMT's photostable characteristics mean it can provide superior UV protection compared to existing options. Its stability under sunlight is particularly critical for ensuring efficacy and consumer safety. Key PointsSolutions BEMT improves consumer sunscreen experience.Promote lightweight, non-greasy formulations to attract users. It enhances broad-spectrum protection.Educate clients on the importance of broad-spectrum sunscreens. Supports skin cancer prevention through better formulation.Encourage regular sunscreen use among your clients. Leverages global standards for UV protection.Stay updated with international UV protection trends. The Implementation of Bemotrizinol in Formulations Should the FDA’s proposal come to fruition, bemotrizinol is expected to open up new avenues for sunscreen formulations. The increased efficiency of BEMT allows cosmetic chemists to achieve targeted SPF levels with lower concentrations, potentially improving the sensory experience of sunscreen products. However, industry players must remain diligent in ensuring that sunscreens formulated with BEMT comply with necessary safety protocols and do not compromise on UV protection. Many manufacturers already possess BEMT formulas for international markets, streamlining the transition should approval be granted. Applying sunscreen that could soon include bemotrizinol. Understanding UV exposure is crucial for effective sun protection. Key PointsSolutions Focus on the effective use of BEMT in formulas.Inquire about product options that include BEMT. Potential market differentiation with BEMT products.Create targeted marketing campaigns highlighting new ingredient. Addressing public concerns over ingredient safety.Host information sessions about ingredient safety and efficacy. Collaboration with manufacturers will drive innovation.Force discussions with suppliers about new product offerings. Conclusion: The Future of Sunscreens with BEMT In summary, the FDA’s proposal to include bemotrizinol could significantly alter the sunscreen landscape in the United States, providing more effective, user-friendly options in sun protection. As medical spa owners, staying informed and engaged with this development is crucial to enhance your product offerings and educate your clients. To navigate this change effectively, consider exploring these actionable steps: Engage with your suppliers regarding BEMT product availability. Educate clients on the importance of sunscreen reapplication. Participate in the public comment period to voice support for bemotrizinol. Train staff on the specifications and benefits of newer sunscreen formulations. Frequently Asked Questions What is bemotrizinol? Bemotrizinol is a chemical UV filter that protects against both UVA and UVB rays and is proposed for use in U.S. sunscreens. Why is this proposal significant? It will expand available sunscreen options and enhance consumer protection against UV damage. When will BEMT be available in the U.S.? While the exact timeline is uncertain, products could begin marketing as early as late 2026, pending FDA approval. Key TakeawaysSolutions BEMT proposal could revolutionize sun protection options.Stay educated on regulatory changes affecting sunscreen. Greater access to safe ingredients for children.Promote sunscreen awareness for family use. Importance of initiating public discussions.Encourage your community to partake in comment periods. Emphasis on ingredient transparency and safety.Provide detailed consultations about sunscreen safety.